December 6, 2021
CTSW Wins Dismissal of $4 Million Action Against Seafood Investor Client

CTSW prevailed in a motion to dismiss a $4 million action against a client, an investor in a shrimp business. The action included allegations of fraud and unjust enrichment based on the investor’s relationship to an estranged wife and a business partner running the business. The court agreed with CTSW’s argument that the fraud allegations, […]

read more
October 4, 2021
Jerry Cohen on Panel Discussing Healthtech Investments

CTSW’s Jerry Cohen was on a panel hosted by the Yale Alumni Health Network and Global Blockchain Business Council on challenges and opportunities in healthtech investments. The panel took place on September 28. A recording of the one-hour discussion is available here. The firm works extensively with healthtech executives, entrepreneurs, and investors.

read more
September 13, 2021
CTSW Represents Licensee in Nutraceutical Licensing and Endorsement Agreements

CTSW represented a licensee in obtaining the rights to manufacture, market, and sell nutraceutical and health foods in Australia. The product is endorsed by a movie celebrity and the agreement includes future promotional appearances. In addition to deep experience in pharmaceutical licensing agreements, CTSW has also represented numerous businesses and celebrities in endorsement and related […]

read more
August 30, 2021
CTSW Represents Seller in $60 Million Co-Op Sale

CTSW represented the seller of a $60 million Upper East Side triplex, the largest co-op transaction in Manhattan since 2015. The firm has represented purchasers and sellers of numerous high-end residential properties. Joe Vann, Larry Tauber, and Daniel Friedman worked on the transaction.

read more